Cancer-associated retinopathy preceding the diagnosis of cancer
- PMID: 30390655
- PMCID: PMC6215635
- DOI: 10.1186/s12886-018-0948-2
Cancer-associated retinopathy preceding the diagnosis of cancer
Abstract
Background: The early diagnosis of cancer is of crucial importance and a key prognostic factor. Cancer-associated retinopathy (CAR) can be symptomatic prior to other manifestations directly related to malignant tumors. The aim of this study was to show that, in selected cases, ophthalmic findings are consistent enough with the diagnosis of CAR to trigger investigations aimed at detecting a previously unknown malignancy.
Methods: This was a monocentric retrospective case series performed in a tertiary referral center. Patients with a diagnosis of CAR were included. Diagnosis was based on the clinical presentation, the visual field and electroretinogram alterations. The clinical presentation, visual field testing and electroretinographic results were analyzed as well as the malignancies identified following the diagnosis of CAR. Follow-up data was collected.
Results: Four patients (two men, two women, median age 65.5 years) were included. All patients presented with posterior segment inflammation at initial presentation as well as advanced visual field loss and an extinguished electroretinogram. The best corrected decimal visual acuity was 0.8 or better in both eyes of three patients and decreased to 0.3 OD and O.2 OS in one patient due to a bilateral macular edema. No patient had a previously known history of cancer. Once the diagnosis of CAR was made, investigations aimed at identifying a malignant tumors subsequently led to the diagnosis of two cases of small cell lung tumors, of one prostate carcinoma and of a uterine sarcoma. The treatment of CAR included plasmapheresis, systemic corticosteroids, azathioprine, cyclosporine and periocular or intraocular corticosteroid injections. In all cases the intraocular inflammation resolved, but pigment mottling, diffuse retinal atrophy, optic disc pallor and arterial narrowing were among manifestations observed during the follow-up of the patients.
Conclusion: In selected patients, findings suggestive of CAR can be useful for the early detection of a cancer.
Keywords: Cancer; Cancer-associated retinopathy; Paraneoplastic retinopathy; Uveitis.
Conflict of interest statement
Ethics approval and consent to participate
Approved in writing by the Ethics Committee of the French Society of Ophthalmology (IRB 00008855 Société Française d’Ophtalmologie IRB#1).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.JAMA Ophthalmol. 2019 May 1;137(5):564-567. doi: 10.1001/jamaophthalmol.2019.0284. JAMA Ophthalmol. 2019. PMID: 30896772 Free PMC article.
-
Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss.Doc Ophthalmol. 2012 Aug;125(1):63-70. doi: 10.1007/s10633-012-9327-0. Epub 2012 May 9. Doc Ophthalmol. 2012. PMID: 22569848 Free PMC article.
-
Paraneoplastic retinopathy associated with occult bladder cancer.Indian J Ophthalmol. 2016 Mar;64(3):248-50. doi: 10.4103/0301-4738.181744. Indian J Ophthalmol. 2016. PMID: 27146943 Free PMC article.
-
Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.Arch Ophthalmol. 1999 Apr;117(4):471-7. doi: 10.1001/archopht.117.4.471. Arch Ophthalmol. 1999. PMID: 10206574 Review.
-
Unilateral cancer-associated retinopathy: a case report.Scott Med J. 2016 Aug;61(3):155-159. doi: 10.1177/0036933015598124. Epub 2015 Aug 4. Scott Med J. 2016. PMID: 26246524 Review.
Cited by
-
Clinical, electrophysiologic and serologic evidence of cancer associated retinopathy preceding a diagnosis of breast cancer.BMJ Case Rep. 2024 Apr 25;17(4):e257911. doi: 10.1136/bcr-2023-257911. BMJ Case Rep. 2024. PMID: 38670565
-
Cancer-Associated Retinopathy due to Clear Cell Renal Carcinoma.Ocul Oncol Pathol. 2021 Mar;7(1):31-35. doi: 10.1159/000511189. Epub 2020 Dec 18. Ocul Oncol Pathol. 2021. PMID: 33796514 Free PMC article.
-
Intravitreal Dexamethasone Implant in Autoimmune Retinopathy.Case Rep Ophthalmol Med. 2023 Mar 31;2023:5670538. doi: 10.1155/2023/5670538. eCollection 2023. Case Rep Ophthalmol Med. 2023. PMID: 37035523 Free PMC article.
-
Ocular Paraneoplastic Syndromes: A Critical Review of Diffuse Uveal Melanocytic Proliferation and Autoimmune Retinopathy.Cancer Control. 2022 Jan-Dec;29:10732748221144458. doi: 10.1177/10732748221144458. Cancer Control. 2022. PMID: 36473045 Free PMC article. Review.
-
Visual loss as the initial manifestation of an ignored disseminated prostate cancer: A case report.Am J Ophthalmol Case Rep. 2022 Nov 8;28:101748. doi: 10.1016/j.ajoc.2022.101748. eCollection 2022 Dec. Am J Ophthalmol Case Rep. 2022. PMID: 36393904 Free PMC article.
References
-
- Scott CL, Cher LM, O’Day J. Cancer associated retinopathy and non-small cell lung cancer. J Clin Neurosci Off J Neurosurg Soc Australas. 1997;4:355–357. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical